Florida Cancer Specialists | Strategic Alliance Partners

October 22, 2021

Three medical oncologists at Florida Cancer Specialists & Research Institute are co-authors on a new integrated safety analysis of umbralisib, used to treat lymphoid malignancies.

October 15, 2021

Michael Diaz, MD will assume the role of President & Managing Physician at Florida Cancer Specialists & Research Institute.

October 14, 2021

Dr. Gordan discusses the advantages of in-house genomic testing, the transition from external to internal sequencing, and the anticipated effects of the move.

October 14, 2021

Expanded in-house testing capabilities enable faster and more accurate diagnosis, prognosis and treatment planning for a wide variety of cancers.

October 05, 2021

Senior leaders of Florida Cancer Specialists & Research Institute have been invited to serve on the faculty for the Association for Value-Based Cancer Care 2021 Summit & Educational Program being held in New York, NY on Oct. 13 – 15.

September 29, 2021

Sarah Cannon recently opened its newest drug development unit in collaboration with Florida Cancer Specialists & Research Institute and The University of Central Florida College of Medicine in Lake Nona, Flordia.

September 20, 2021

Dr. Dietrich discusses the latest developments with immunotherapy and targeted therapy in stage III non–small cell lung cancer.

September 03, 2021

Martin Dietrich, MD, PhD, discusses future research directions for the treatment of patients with lung cancer. 

August 27, 2021

Since 2016, Florida Cancer Specialists & Research Institute has been a national leader in the transition of oncology care from a fee-for-service reimbursement structure to fee-for-value.

August 25, 2021

Martin Dietrich, MD, PhD, shares how he navigates the non–small cell lung cancer (NSCLC) treatment landscape.

August 25, 2021

A survey of more than 6,800 cancer patients conducted this month by Florida Cancer Specialists & Research Institute found that patients overwhelmingly prefer that the FCS physicians, nurses and staff members who provide their care are vaccinated and wear masks to reduce the spread of COVID-19 and provide a safe environment within clinics.

July 22, 2021

June 28, 2021

Streamlined processes afforded by in-house genomic testing have the potential to provide clinical, collaborative, and financial benefits.

March 29, 2019

Following a multiyear trend in which oncology practices merged with hospitals to achieve savings and improved care, it appeared as though the pendulum was going to swing the other way.

February 05, 2019

With hugely destructive storms now almost routine—3 of the 5 costliest hurricanes on record occurred in 2017—the secret to practice readiness is constant review and analysis.

August 11, 2018

Abemaciclib (Verzenio) has emerged as a promising agent for patients with hormone receptor-positive, HER2-negative metastatic breast cancer, according to Lowell L. Hart, MD.

January 27, 2018

Doctors from Intermountain Healthcare decided to see if they could improve outcomes of patients placed on expensive machines.

November 23, 2017

As CMS moves ahead with payment reforms designed to reduce the total cost of hospital care, the results from a new study show that cancer treatment remains much less expensive at community oncology clinics than at hospitals and that the spending gap between the 2 types of sites may be growing wider.

November 06, 2017

Texas Oncology and Florida Cancer Specialists (FCS) knew their ability to recover from hurricanes Harvey and Irma would hinge upon the work they did before either storm arrived.

October 27, 2017

As the Oncology Care Model practices work to reduce Medicare’s overall spending on those patients and to earn shared savings payments, the data are providing them with an unprecedented full picture of the extent and cost of care.